Eve & Co Incorporated, through its subsidiary, Natural MedCo Ltd., produces and sells dried cannabis, cannabis plants, and cannabis seeds in Canada. It focuses on the distribution of recreational cannabis for women under the EVE brand. The company is headquartered in Strathroy, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone416-922-9096
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$413,711.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date8/19/2019 (Estimated)
OptionableNot Optionable
Eve & Co Inc (CVE:EVE) Frequently Asked Questions
What is Eve & Co Inc's stock symbol?
Eve & Co Inc trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EVE."
When is Eve & Co Inc's next earnings date?
What price target have analysts set for EVE?
1 equities research analysts have issued 12-month price targets for Eve & Co Inc's shares. Their forecasts range from C$1.08 to C$1.08. On average, they anticipate Eve & Co Inc's stock price to reach C$1.08 in the next year. This suggests a possible upside of 191.9% from the stock's current price. View Analyst Price Targets for Eve & Co Inc.
What is the consensus analysts' recommendation for Eve & Co Inc?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eve & Co Inc in the last year. There are currently 1 strong buy rating for the stock, resulting in a consensus recommendation of "Strong Buy." View Analyst Ratings for Eve & Co Inc.
Has Eve & Co Inc been receiving favorable news coverage?
Media stories about EVE stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Eve & Co Inc earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Eve & Co Inc.
Who are some of Eve & Co Inc's key competitors?
Some companies that are related to Eve & Co Inc include Flowr (FLWR), ICC Labs (ICC), Benchmark (BMK), Shield Therapeutics (STX), WeedMD (WMD), Althea Group (AGH), Harvest One Cannabis (HVT), Auscann Group (AC8), Depomed (ASRT), Probiotec (PBP), Delta 9 Cannabis (NINE), Biosyent (RX), Invion (IVX), Science in Sport (SIS) and MGC Pharmaceuticals (MXC).
What other stocks do shareholders of Eve & Co Inc own?
Who are Eve & Co Inc's key executives?
Eve & Co Inc's management team includes the folowing people:
- Ms. Melinda Rombouts, Founder, CEO & Pres
- Mr. David Burch, Founder
- Mr. Landon Roedding, Chief Financial Officer
- Mr. Richard M. Kimel, Corp. Sec. (Age 52)
How do I buy shares of Eve & Co Inc?
Shares of EVE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Eve & Co Inc's stock price today?
One share of EVE stock can currently be purchased for approximately C$0.37.
How big of a company is Eve & Co Inc?
What is Eve & Co Inc's official website?
How can I contact Eve & Co Inc?
The company can be reached via phone at 416-922-9096.
MarketBeat Community Rating for Eve & Co Inc (CVE EVE)
MarketBeat's community ratings are surveys of what our community members think about Eve & Co Inc and other stocks. Vote "Outperform" if you believe EVE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVE will underperform the S&P 500 over the long term. You may vote once every thirty days.
